Mirko Wäckerle
Directeur/Membre du Conseil chez Zweite DEWB Vermögensverwaltungs AG
Profil
Mirko Wäckerle is currently the Plant Director at SMARTRAC TECHNOLOGY Dresden GmbH.
He also holds positions as a Member-Supervisory Board at JENOPTIK siebente Vermögens AG and Zweite DEWB Vermögensverwaltungs AG.
In the past, he served as the Director at Integrated Genomics, Inc. and as a Member-Management Board at Deutsche Effecten & Wechsel Beteiligungs AG.
Additionally, he was a Member of the Management Board at DEWB AG (Venture Capital) from 2010 to 2011.
Postes actifs de Mirko Wäckerle
| Sociétés | Poste | Début |
|---|---|---|
| Zweite DEWB Vermögensverwaltungs AG | Directeur/Membre du Conseil | 03/06/2010 |
| JENOPTIK siebente Vermögens AG | Directeur/Membre du Conseil | 03/06/2010 |
SMARTRAC TECHNOLOGY Dresden GmbH
 SMARTRAC TECHNOLOGY Dresden GmbH Electronic Production EquipmentElectronic Technology SMARTRAC TECHNOLOGY Dresden GmbH engages in the design, manufacture, and testing of electronic and electromechanical components, particularly miniaturized components. It specializes in technologies for the production of electronic circuit boards, installation of microassemblies, as well as the development and manufacture of equipment for the production and testing of microasseblies. The company was founded in November 1994 and is headquartered in Dresden, Germany. | Corporate Officer/Principal | - |
Anciens postes connus de Mirko Wäckerle
| Sociétés | Poste | Fin |
|---|---|---|
DEWB AG (Venture Capital)
 DEWB AG (Venture Capital) Investment ManagersFinance DEWB AG (Venture Capital) (DEWB-VC) is the venture capital subsidiary of Deutsche Effecten & Wechsel Beteiligungs AG (FR: EFF), headquartered in Jena, Germany. The firm, established in 1997, provides equity capital, corporate development expertise and network support to strong growth, medium-sized technology companies. | Directeur Financier/CFO | 31/12/2011 |
| DEUTSCHE EFFECTEN- UND WECHSEL-BETEILIGUNGSGESELLSCHAFT AG | Corporate Officer/Principal | - |
Integrated Genomics, Inc.
 Integrated Genomics, Inc. Miscellaneous Commercial ServicesCommercial Services Founded in 1997, Chicago-based Integrated Genomics™ specializes in research in microbial genomics, biochemistry, and gene expression. Its scientists has broad experience in both in silico and wet lab sequencing, research and development with more than 100 relevant publications in these areas. Integrated Genomics™ has particularly long-standing relationships and active research in the area of lactic acid bacteria and pathogenic microbes, as well as a broad customer base across industry, academic and government institutions. Integrated Genomics™' products and services are based on ERGO™, its web-based genome analysis platform. ERGO™ integrates proprietary functional genomic data, metabolic reconstructions, expression profiling, and biochemical and microbiological data with publicly available information. Focused on microbial genomics, ERGO™ provides better and faster identification of gene function across all organisms. In 2010 Integrated Genomics, Inc.'s business operations were transitioned to a new corporation, IG Assets, Inc. With the original Integrated Genomics' team, IG Assets continues to provide the same ERGO-based microbial genomic products and service. | Directeur/Membre du Conseil | 10/06/2011 |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| DEUTSCHE EFFECTEN- UND WECHSEL-BETEILIGUNGSGESELLSCHAFT AG | Finance |
| Entreprise privées | 5 |
|---|---|
DEWB AG (Venture Capital)
DEWB AG (Venture Capital) Investment ManagersFinance DEWB AG (Venture Capital) (DEWB-VC) is the venture capital subsidiary of Deutsche Effecten & Wechsel Beteiligungs AG (FR: EFF), headquartered in Jena, Germany. The firm, established in 1997, provides equity capital, corporate development expertise and network support to strong growth, medium-sized technology companies. | Finance |
Integrated Genomics, Inc.
Integrated Genomics, Inc. Miscellaneous Commercial ServicesCommercial Services Founded in 1997, Chicago-based Integrated Genomics™ specializes in research in microbial genomics, biochemistry, and gene expression. Its scientists has broad experience in both in silico and wet lab sequencing, research and development with more than 100 relevant publications in these areas. Integrated Genomics™ has particularly long-standing relationships and active research in the area of lactic acid bacteria and pathogenic microbes, as well as a broad customer base across industry, academic and government institutions. Integrated Genomics™' products and services are based on ERGO™, its web-based genome analysis platform. ERGO™ integrates proprietary functional genomic data, metabolic reconstructions, expression profiling, and biochemical and microbiological data with publicly available information. Focused on microbial genomics, ERGO™ provides better and faster identification of gene function across all organisms. In 2010 Integrated Genomics, Inc.'s business operations were transitioned to a new corporation, IG Assets, Inc. With the original Integrated Genomics' team, IG Assets continues to provide the same ERGO-based microbial genomic products and service. | Commercial Services |
| Zweite DEWB Vermögensverwaltungs AG | |
| JENOPTIK siebente Vermögens AG | |
SMARTRAC TECHNOLOGY Dresden GmbH
SMARTRAC TECHNOLOGY Dresden GmbH Electronic Production EquipmentElectronic Technology SMARTRAC TECHNOLOGY Dresden GmbH engages in the design, manufacture, and testing of electronic and electromechanical components, particularly miniaturized components. It specializes in technologies for the production of electronic circuit boards, installation of microassemblies, as well as the development and manufacture of equipment for the production and testing of microasseblies. The company was founded in November 1994 and is headquartered in Dresden, Germany. | Electronic Technology |
